Startup Champions Seed Night

 

(Cet évènement se déroule en anglais)

The Startup Champions Seed Night is an annual startup presentation event bringing together the most promising entrepreneurs from EPFL and beyond, angel investors, mentors, industry leaders and scientists for an audience of 250+ people. The objective of the event is to showcase fast-growing entrepreneurial projects to the community and educate the audience about seed investment.

REGISTER HERE
EPFL Alumni contributing members benefit from a special discount (CHF 30.- instead of CHF 50.-).
The event is free for EPFL students, PhD and postdocs. Please mention the SCIPER number that matches your name to benefit from a free ticket. Your number will be verified by the organizers.

 

Program of the 2018 edition, May 2nd

17:00 Doors open for startups exhibition
18:30 Welcome words
19:00 Keynote, Daniel Yanisse, Founder & CEO Checkr, EPFL Alumni MT’12
19:15 Pitch competition
20:15 Prix Isabelle Musy, Award Ceremony for a woman entrepreneur
20:30 Final with the four best startups
20:45 Buffet networking and startups exhibition

 

 

   

Daniel Yanisse co-founded Checkr in 2014 and has grown it from a simple product to a service used by thousands of companies and millions of jobseekers. As CEO, he likes to build great products and teams and is responsible for setting the strategic direction for the company. Prior to Checkr, he worked on prototypes for Mars rovers at NASA and held engineering roles at startups in the transportation and mobile industries. Daniel is an EPFL Alumnus MT’12.

 

The 20 startups that will take part in the pitch competition:

 

Represented by Guillaume Petit-Pierre, Co-Founder

We developed a disruptive medical device allowing neuroradiologists to navigate in brain arteries 3 times faster and safer than any other available solutions. With this system the surgeon can steer the device head in real time which improves outcomes of stroke-related procedures.

 

Represented by Mathieu Horras, CEO

Every year, 64mio of gynecological treatments require access to the uterus. Standard
use of Tenaculum forceps is painful, traumatic and poses a cross-contamination risk.
Aspivix, a new generation of single-use forceps featuring a suction pad, reduces pain
and eliminates lesions & cross-contamination.

 

Represented by Jeyran Hezaveh, CEO & Co-Founder

Our high performance, Digital Active Noise Cancellation (ANC) Technology is a patent pending SW/HW solution that minimizes unwanted/disruptive audio noise in products such as:
-Voice communication devices: phone, conferencing
-Voice activated smart devices: smartphone/TV/smart speaker, connected home/car
-Hearables: headphone, hearing aid

 

Represented by Christian Leisner, CEO

In CDR-Life we make novel immunotherapies that work like CAR-T but better. Our trispecific biologics are superior to the most advanced therapies based on tests in bone marrow samples from patients with multiple myeloma, the 3rd most common blood cancer. As a proven team with a validated technology, we expand this trispecific concept to other cancers.

 

Represented by Tomas Sluka, CEO

CREAL3D develops critical component for smart glasses, which will enable to make them small and pleasant to wear throughout the day, letting wearers to fuze virtual objects into the real world seamlessly, obviating the need for screens as we know them today.

 

Represented by Daniela Marino, CEO

Every year, million of people suffer from skin defects (e.g. burs) and need surgical intervention.
Unfortunately, standard of care often leaves these patients with disfiguring and
highly debilitating scars. At Cutiss we can create large quantities of minimally scarring
skin that can finally improve life quality of patients worldwide.

 

Represented by Mario Michan, CEO

Daphne Technology’s exhaust gas cleaning technology can help the marine industry to
comply with international Sulphur Oxide (SOx) and Nitrogen Oxide (NOx) air emission
regulations in the most economical and environmentally friendly manner available, potentially
saving ship owners up to 50% in fuel costs in 2020, and increasing its competitiveness.

 

Represented by Adriano Garonna, Co-Founder

Non-invasive and automated treatments of heart arrhythmias using proton beams.

 

Represented by Olivia Grebler, Founder and CEO

Ecocook is the only Swiss certification program, allowing restaurants to improve their
performance, reduce costs, reduce their environmental and social impacts, and differentiate
from competitors. Through:
-Restaurant sustainability consulting
-Sustainable Restaurant Certification
-Ecocook’s website and social networks

 

Represented by Anne Schmidt, CEO

Elthera AG is a Swiss biotech company developing a first-in-class antibody against the
novel target L1CAM using a personalized health care approach. The compound is expected
to be efficacious in many tumors with preclinical Proof-of-Concept demonstrated
in several mouse tumor models.

 

Represented by Hadrien Michaud, CEO

Feeltronix stretches the current mechanical limitations of circuit board technologies. We
provide design and manufacturing solutions for in-rubber structural electronics. Feeltronix-
enabled devices are highly conformal and can withstand repeated and extreme
mechanical deformations.

 

Represented by Samir Ounzain, CEO

HAYA Therapeutics is dedicated to treating heart failure through the discovery and development
of innovative targeted first-in-class RNA-based therapeutics, with a specific
focus on long noncoding RNAs.

 

Represented by Simon Bachmann, CEO

IDUN Technologies Ltd. is a biosensor company based in Zurich, Switzerland. Coming
from a stretchable electronics research group from ETH Zurich, IDUN is developing and
producing soft and dry conductive electrodes for biopotential monitoring (ECG, EEG,
EMG). With a unique and patented surface structure these electrodes provide high quality
signals with skin-friendly materials without electrolyte gel or glue.

 

Represented by Javier Bello Ruiz, CEO & Co-Founder

IMVERSE is a spin-off from EPFL developing software and providing services for Mixed
Reality content creation.
Our volumetric solutions reduce the time and money spent on production phases of VR
movies and Hollywood movies by a factor of 10.
This is only possible thanks to our proprietary voxel-based rendering and simulation graphics
engine, and our easy and fast process to transform a single 360-degree 2D picture
into a 3D room-scale experience with live hologram actors and real-time VFX.

 

Represented by Naomi MacKenzie, Co-Founder

KITRO provides the food and beverage outlets with the world’s first fully automated food
waste management solution, which empowers users to reduce their costs while having
a positive impact on the environment.

 

Represented by Aldo Podesta, CEO

L2F is a company active in the conception, development and maintenance of complex
predictive models. Heavily focused on mathematical research, L2F aims to make available
the best analysis tools to its clients, in particular large companies and public institutions.

 

Represented by Sami Arpa, CEO and Co-Founder

Largo creates Sofy.tv as a short film distribution platform that creates new distribution
channels for short-film makers and gives the chance of enjoying the increasing quality
of short films to a wide audience. By providing strong deep-learning based features, we
provide a high level of user engagement in the film watching experience. Short films
(films less than 40 minutes) are today becoming mainstream, unlike a few years ago that
they were considered niche and only for dedicated cinephile audience. We are in the
best timing for exploiting this change in the market.

 

Represented by Matteo Cornaglia, CEO and Founder

Nagi Bioscience introduces the first Organism-on-Chip technology, as key to accelerate
drug/chemical discovery. A fully automated device enables culture, treatment and highcontent
analysis of microscopic worms, for rapid and cost-effective in vivo testing of
drug/chemical toxicity and efficacy.

 

Represented by Pierre Baque, CEO

Neural Concept accelerates the engineering process for industrial companies using innovative,
deep-learning algorithms. This allows our customers to optimize the design
process by formulating engineering decisions as the outcome of a straightforward optimization
problem.

Represented by Kevin Mamalis, Co-Founder

Thanks to innovative machinery Swiss Motion Technologies produces and sells mass
customised medical grade mobility equipment. The company places a particular focus
on orthotics and prosthetics with one goal: to vastly improve quality of life by providing
everyone with the opportunity to benefit from the best rehabilitation comfort and efficiency.

 

 

You can find here all the pictures of the 2017 event.

 

The event is kindly supported by: